Zusammenfassung
Der Beginn mancher Formen von Hypertonie sowie die Entwicklung der akzelerierten Phase der essentiellen Hypertonie spiegelt das Wirken eines oder mehrer hormonaler Pressorfaktoren wider, wie z. B. gesteigerte Aktivität des Renin-Angiotensin-Systems oder Mineralokortikoidüberschuß. Von nicht geringerer Bedeutung für die Blutdruckregulation ist das Versagen von Gegenkräften, die normalerweise eine Senkung des Blutdrucks bewirken. Das Kallikrein-Kinin-System besitzt die erforderlichen Eigenschaften, diese Funktion wahrzunehmen, insbesondere wenn man es unter dem Aspekt seiner Wechselwirkung mit Prostaglandinen betrachtet [84] (Abb. 1). Ein Ausbleiben der normalen Ausgleichsfunktion kann eine anhaltende Hypertonie verursachen ohne Aktivitätszunahme irgendeines Pressorfaktors. So kann, wenn man von der tonischen Aktivität entgegenwirkender Blutdruckregulationssysteme ausgeht, eine Dysfunktion im Vasodepressorsystem zu Hypertonie führen, ohne daß eine Zunahme der Grundaktivität des blutdruckerhöhenden Systems erfolgt. Innerhalb der Niere, und wahrscheinlich auch in den extrarenalen Blutgefäßen, stehen Prostaglandine in Wechselwirkung mit den hauptsächlichen Blutdruckregulationssystemen, dem Kallikrein-Kinin-System und dem adrenerg inner-vierten Renin-Angiotensin-System, unter Verstärkung des ersteren und Pufferung des letzteren [143]. Damit tragen Prostaglandine zur blutdrucksenkenden Wirkung der Kinine bei und machen die blutdruckerhöhende Wirkung von Angiotensinen zunichte. Eine verminderte Reaktionsfähigkeit des renalen Kallikreinsystems zeigte sich bei einigen Formen von Hypertonie beim Menschen und im Experiment [63, 79].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahnfelt-Ronne I, Arrigoni-Martelli E (1978) Increased PGF2a synthesis in renal papilla of spontaneously hypertensive rats. Biochem Pharmacol 27: 2363–2367
Aiken JW (1974) Effects of prostaglandin synthesis inhibitors on angiotensin tachyphylaxis in the isolated coeliac and mesenteric arteries of the rabbit. Pol J Pharmacol Pharm 26: 217–227
Aiken JW, Vane JR (1973) Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther 183: 678–687
Armstrong JM, Lattimer N, Moncada S, Vane JR (1978) Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandinF,a with those of prostaglandin E2 in rats and rabbits. Br J Pharmacol 62: 125–130
Baer PG, Cagen LM (1981) Renal prostaglandin excretion and metabolism in male and female New Zealand normotensive and genetically hypertensive rats. Hypertension 3: 257–261
Bartter FC, Pronove P, Gill JR Jr, MacCardle RC (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 33: 811–828
Bayliss WM (1902) On the local reaction of the arterial wall to changes in internal pressure. J Physiol 28: 220–231
Beaty O III, Donald DE (1979) Contribution of prostaglandins to muscle blood flow in anesthetized dogs at rest, during exercise, and following inflow occlusion. Circ Res 44: 67–75
Beilin LJ, Bhattacharya J (1977) The effect of prostaglandin synthesis inhibitors on renal blood flow distribution in conscious rabbits. J Physiol 269: 395–405
Benzoni D, Vincent M, Sassard J (1982) Urinary prostaglandins in the Lyon strains of hypertensive, normotensive, and low blood pressure rats. Hypertension 4: 325–328
Berl T, Raz A, Wald H, Horowitz J, Czaczkes W (1977) Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am J Physiol 323 (6): F529 - F537
Bevan VH, Pierce JV, Pisano JJ (1971) A sensitive isotopic procedure for the assay of esterase activity: measurement of human urinary kallikrein. Clin Chem Acta 32: 67–73
Bunting S, Gryglewski R, Moncada S, Vane JR (1976) Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 12: 897–915
Campbell WB, Holland OB, Adams BV, Gomez-Sanchez CE (1982) Urinary excretion of prostaglandin E2, prostaglandin F2a, and thromboxane B2 in normotensive and hypertensive subjects on varying sodium intakes. Hypertension 4: 735–741
Carone FA, Pullman TN, Oparil S, Nakamura S (1976) Micropuncture evidence of rapid hydrolysis of bradykinin by rat proximal tubule. Am J Physiol 230: 1420–1424
Carr AA (1970) Hemodynamic and renal effects of a prostaglandin, PGA(1) in subjects with essential hypertension. Am J Med Sci 259: 21–26
Carretero OA, Scicli AG (1976) Renal kallikrein: its localization and possible role in renal function. Fed Proc 35: 194–198
Chaignon M, Ruffle ML, Lucsko M, Cuche JL, Guedon J (1982) Prostacyclin infusion in hypertension: Acute hemodynamic and hormonal effects. N Engl J Med 307: 559
Chrysant SG, Townsend SM, Morgan PR (1978) The effects of salt and meclofenamate administration on the hypertension of spontaneously hypertensive rats. Clin Exp Hypertension 1: 381–391
Coleman RW (1974) Formation of human plasma kinin. N Engl J Med 291: 509–515
Colina-Chourio J, McGiff JC, Miller MP, Nasjletti A (1976) Possible influence of intrarenal generation of kinins on prostaglandin release from the rabbit perfused kidney. Br J Pharmacol 58: 165–172
Colina-Chourio J, McGiff JC, Nasjletti A (1979) Effect of indomethacin on blood pressure in the normotensive unanesthetized rabbit: Possible relation to prostaglandin synthesis inhibition. Clin Sci 57: 359–365
Damas J, Bourdon V (1974) Libération d’acide arachidonique par la bradykinine. Comptes Rendus des Séances de la Société de Biologie et de Ses Filiales 168: 1445–1448
DeJong PE, Donker MM, Van der Wall E, Erkelens DW, Van der Hem GK, Doorenbos H (1980) Effect of indomethacin in two siblings with a renin-dependent hypertension, hyperaldosteronism and hypokalemia. Nephron 25: 47–52
DuCharme DW, Weeks JR, Montgomery RC (1968) Studies on the mechanism of the hypertensive effect of prostaglandin F2a. J Pharmacol Exp Ther 160: 1–10
Dunn MJ (1976) Renal prostaglandin synthesis in the spontaneously hypertensive rat. J Clin Invest 58: 862–870
Durâo V, Prata MM, Gonçalves LMP (1977) Modification of antihypertensive effect of /3adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet 2: 1005–1007
Dusting GJ, Moncada S, Vane JR (1978) Recirculation of prostacyclin (PGI2) in the dog. Br J Pharmacol 64: 315–320
Elliot AH, Nuzum FR (1934) Urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 18: 462–474
Ellis EF, Oelz O, Roberts LJ, Payne NA, Sweet-man BJ, Nies AS, Oates JA (1976) Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science 193: 1135–1137
Erdös EG (1975) Angiotensin I converting enzyme. Circ Res 36: 247–255
Erdös EG (1976) The kinins. A status report. Biochem Pharmacol 25: 1563–1569
Folkow B, Neil E (1971) The Principles of Vascular Control. In: Folkow B, Neil E (eds) Circulation. Oxford University Press, New York, pp 285–306
Frölich JC, Sweetman BJ, Can K, Hollifield JW, Oates JA (1975) Assessment of the levels of PGA2 in human plasma by gas chromatography mass spectrometry. Prostaglandins 10: 185–195
Frölich JC, Hollifield JW, Dormois JC, Frölich BL, Seyberth H, Michelakis AM, Oates JA (1976) Suppression of plasma renin activity by indomethacin in man. Circ Res 39: 447–452
Frölich JC, Hollifield JW, Oates JA (1976) Reduction of plasma renin activity by inhibition of cyclo-oxygenase: independence of sodium retention. Clin Res 24: 271A
Galvez OG, Bay WH, Roberts BW, Ferris TF 276 J. M. Sullivan und J. C. McGiff (1977) The hemodynamic effects of potassium deficiency in the dog. Circ Res 40: I-11-I-16
Gerber JG, Nies AS (1979) The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses. Circ Res 44: 406–410
Gill JR, Frölich JC, Bowden RE, Taylor AA, Keiser HR, Seyberth HW, Oates JA, Bartter FC (1976) Bartter’s syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med 61: 43–51
Gimeno MF, Sterin-Borda L, Borda ES, Lazzari MA, Gimeno AL (1980) Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries. Prostaglandins 19: 907–916
Granström E (1977) Metabolism of prostaglandins. In: Berti F, Samuelsson B, Velo GP (eds) Prostaglandins and Thromboxanes. Plenum Press, New York, pp 75–83
Grantham JJ, Orloff J (1968) Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3’, 5’-monophosphate, and theophylline. J Clin Invest 47: 1154–1161
Grodzinska L, Gryglewski RJ (1980) Angiotensin-induced release of prostacyclin from per-fused organs. Pharmac Res Commun 12: 339–347
Gryglewski RJ, Korbut R, Ocetkiewicz A (1978) Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature 273: 765–767
Guyton AC, Coleman TG, Cowley AW Jr, Manning RD Jr, Norman RA Jr, Ferguson JD (1974) A systems analysis approach to understanding long-range arterial blood pressure control and hypertension. Circ Res 35: 159–176
Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS (1977) Bartter’s syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann Intern Med 87: 281–286
Hamberg M, Samuelsson B (1974) Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71: 3400–3404
Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994–2998
Hedqvist P (1970) Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissues. Acta Physiol Scand (Suppl) 345: 1–40
Hensby CN, Dollery CT, Barnes PJ, Dargie H (1979) Production of 6-oxo-PGF1a by human lung in vivo. Lancet 2: 1162–1163
Hollenberg NK, Solomon HS, Adams DF, Abrams HL, Merrill JP (1972) Renal vascular responses to angiotensin and norepinephrine in normal man. Circ Res 31: 750–757
Hong SL, Levine L (1976) Stimulation of prostaglandin synthesis by bradykinin and thrombin and their mechanisms of action on MC5–5 fibroblasts. J Biol Chem 251: 5814–5816
Hoult JR, Moore PK (1977) Pathways of prostaglandin Fla metabolism in mammalian kidneys. Br J Pharmacol 61: 615–626
Hoult JRS, Lofts FJ, Moore PK (1981) Stability of prostacyclin in plasma and its transformation by platelets to a stable spasmogenic product. Proc Br J Pharmacol Soc 68 (abstract)
Hulthén UL, Lecerof H, Hökfelt B (1977) Renal venous output of kinins in patients with hypertension and unilateral renal artery stenosis. Acta Med Scand 202: 189–191
Ishii M, Uehara Y, Hirata Y, Atarashi K, Ikeda T, Susimoto T, Takeda T, Murao S (1982) Effects of norepinephrine infusion on systemic hemodynamics and plasma 6-keto-prostaglandin Fla in normotensive subjects and patients with essential hypertension. Jpn Circ J 46 (5): 494–502
Itskovitz HD, McGiff JC (1974) Hormonal regulation of the renal circulation. Circ Res 34 (Supp11): 65–73
Itskovitz HD, Terragno NA, McGiff JC (1974) Effect of a renal prostaglandin on distribution of blood flow in the isolated canine kidney. Circ Res 34: 770–776
Jackson EK, Herzer WA, Zimmerman JB, Branch RA, Oates JA, Gerkens JF (1981) 6-ketoprostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue. J Pharmacol Exper Ther 216: 24–27
Jackson EK, Heideman HT, Branch RA, Ger-kens JF (1982) Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGF, vasodilate the in vivo rat kidney. Circ Res 51: 67–72
Janszen FHA, Nugteren DH (1971) Histochemical localisation of prostaglandin synthetase. Histochemie 27: 159–164
Keiser HR, Andrews MJ Jr, Guyton RA, Margolius HS, Pisano JJ (1976) Urinary kallikrein in dogs with constriction of one renal artery. Proc Soc Exp Biol Med 151: 53–56
Keiser HR, Geller RG, Margolius HS, Pisano JJ (1976) Urinary kallikrein in hypertensive animal models. Fed Proc 35: 199–202
Larsson C, Änggard E (1973) Regional differences in the formation and metabolism of prostaglandins in the rabbit kidney. Eur J Pharmacol 21: 30–36
Larsson C, Weber P, Änggard E (1974) Arachidonic acid increases and indomethacin decreases plasma renin activity in the rabbit. Eur J Pharmacol 28: 391–394
Lebel M, Grose JH (1982) Renal prostaglandins in borderline and sustained essential hypertension. Prostaglandins-Leukotrienes-Med 8 (5): 409–418
Lee JB, Crowshaw K, Takman BH, Attrep KA, Gougoutas JC (1967) Identification of prostaglandins E2, F2a and A2 from rabbit kidney medulla. Biochem J 105: 1251–1260
Levy SB, Lilley JJ, Frigon RP, Stone RA (1977) Urinary kallikrein and plasma renin activity as determinants of renal blood flow: the influence of race and dietary sodium intake. J Clin Invest 60: 129–138
Lima DR, Turner P (1982) Beta-blocking drugs increase responsiveness to prostacyclin in hypertensive patients. Lancet 2: 444
Limas CJ, Limas C (1977) Prostaglandin metabolism in the kidneys of spontaneously hypertensive rats. Am J Physiol 233 (1): H87 - H92
Lonigro AJ, Itskovitz HD, Crowshaw K, McGiff JC (1973) Dependency of renal blood flow on prostaglandin synthesis in the dog. Circ Res 32: 712–717
Malik KU (1978) Prostaglandin-mediated inhibition of the vasoconstrictor responses of the isolatet perfused rat splenic vasculature to adrenergic stimuli. Circ Res 43 (2): 225–233
Malik KU (1978) Prostaglandins–modulation of adrenergic nervous system. Fed Proc 37: 203–207
Malik KU, McGiff JC (1975) Modulation by prostaglandins of adrenergic transmission in the isolated perfused rabbit and rat kidney. Circ Res 36: 599–609
Malik KU, McGiffJC (1976) Cardiovascular actions of prostaglandins. In: Karim SMM (ed) Prostaglandins: Physiological, pharmacological and pathological aspects. MTP Press, Lancaster, pp 103–200
Malmsten C, Hamberg M, Svensson J, Samuels-son B (1975) Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci USA 72: 1446–1450
Margolius HS, Geller R, de Jong W, Pisano JJ, Sjoerdsma A (1972) Altered urinary kallikrein excretion in rats with hypertension. Circ Res 30: 358–362
Margolius HS, Horwitz D, Pisano JJ, Keiser HR (1974) Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res 35: 820–825
Margolius HS, Horwitz D, Pisano JJ, Keiser HR (1976) Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease. Fed Proc 35: 203–206
Marin-Grez M (1974) The influence of antibodies against bradykinin on isotonic saline diuresis in the rat. Pflügers Arch 350: 231–239
Marin-Grez M, Cottone P, Carretero A (1972) Evidence for an involvement of kinins in regulation of sodium excretion. Am J Physiol 223: 794–796
Marin-Grez M, Schaechtelin G, Bonner G, Speck G, Ganten D, Groß F (1982) Renal kallikrein activity and urinary kallikrein excretion in rats with experimental renal hypertension. Clin Sci 63 (4): 349–354
McGiff JC (1977) Bartter’s syndrome results from an imbalance of vasoactive hormones. Ann Intern Med 87: 369–372
McGiff JC, Nasjletti A (1976) Kinins, renal function and blood pressure regulation. A symposium of the American Society for Pharmacology and Experimental Therapeutics presented at the 59th Annual Meeting of the Federation of American Societies for Experimental Biology, Atlantic City, New Jersey, 1975. ( Chairman, McGiff JC). Fed Proc 35: 172–174
McGiff JC, Terragno NA, Strand JC, Lee JB, Lonigro AJ, Ng KKF (1969) Selective passage of prostaglandins across the lung. Nature 223: 742–745
McGiff JC, Crowshaw K. Terragno NA, Lonigro AJ (1970) Release of a prostaglandin-like substance into renal venous blood in response to angiotensin II. Circ Res 26–27 (Suppl 1): 121–130
McGiff JC, Crowshaw K, Terragno NA, Lonigro AJ (1970) Renal prostaglandins: possible regulators of the renal actions of pressor hormones. Nature 227: 1255–1257
McGiff JC, Terragno NA, Malik KU, Lonigro AJ (1972) Release of prostaglandin E-like substance from canine kidney by bradykinin. Circ Res 31: 36–43
McGiff JC, Itskovitz HD, Terragno NA (1975) The action of bradykinin and eledoisin in the canine isolated kidney; relationships to prostaglandins. Clin Sci Mol Med 49: 125–131
McQueen D, Bell K (1976) The effects of prostaglandin E1 and sodium meclofenamate on blood pressure in renal hypertensive rats. Eur J Pharmacol 37: 223–235
Meneely GR, Ball COT, Youmans JB (1957) Chronic sodium chloride toxicity: the protective effect of added potassium chloride. Ann Int Med 47: 263–273
Mersey JH, Williams GH, Hollenberg NK, Dluhy RG (1977) Relationship between aldosterone and bradykinin. Circ Res 40 (Suppl 1): 184–188
Messina EJ, Weiner R, Kaley G (1975) Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibitors of prostaglandin synthesis in rat skeletal muscle. Circ Res 37: 430–437
Mills IH, MacFarlane NAA, Ward PE, Obika LFO (1976) The renal kallikrein-kinin system and the regulation of salt and water excretion. Fed Proc 35: 181–188
Moncada S, Higgs EA, Vane JR (1977) Human arterial and venous tissues generate prostacyclin
J. M. Sullivan und J. C. McGiff (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1: 18–20
Moncada S, Korbut R, Bunting S, Vane JR (1978) Prostacyclin is a circulating hormone. Nature 273: 767–768
Morrison A, Nishikawa K, Needleman P (1977) Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidney. Nature 267: 259–260
Muirhead EE, Leach BE, Byers LW, Brooks B, Daniels EG, Hinman JW (1971) Antihypertensive neutral renomedullary lipids (ANRL). In: Fisher JW (ed) Kidney Hormones. Academic Press, New York, pp 485–506
Muirhead EE, Brooks B, Brosius WL (1976) Indomethacin and blood pressure control. J Lab Clin Med 88: 578–583
Mullane KM, Moncada S (1980) Prostacyclin release and the modulation of some vasoactive hormones. Prostaglandins 20: 25–49
Nakano JM, McCurdy JR (1967) Cardiovascular effects of prostaglandin El. J Pharmacol Exp Ther 156: 538–547
Nanra RS, Chirawong P, Kincaid-Smith P (1973) Medullary ischemia in experimental analgesic nephropathy - the pathogenesis of renal papillary necrosis. Aust N. Z. Med 3: 580–586
Nasjletti A, Colina-Chourio J (1976) Interaction of mineralocorticoids, renal prostaglandins and the renal kallikrein-kinin system. Fed Proc 35: 189–193
Nasjletti A, Malik KU (1981) Interrelations between prostaglandins and vasoconstrictor hormones: Contribution to blood pressure regulation. Med Clin North Am 65: 881–889
Nasjletti A, Colina-Chourio J, McGiffJC (1975) Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition. Circ Res 37: 59–65
Nasjletti A, McGiffJC, Colina-Chourio J (1978) Interrelationships of the renal kallikrein-kinin and prostaglandin systems in the conscious rat: Influence of mineralocorticoids. Circ Res 43: 799–807
Needleman P, Raz A, Ferrendelli JA, Minkes M (1977) Application of imidazole as a selective inhibitor of thromboxane synthetase in human platelets. Proc Natl Acad Sci USA 74: 1716–1720
Negus P, Tannen RL, Dunn MJ (1976) Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man. Prostaglandins 12: 175–180
Nowak J, Wennmalm Ä (1978) Influence of indomethacin and prostaglandin E1 on total and regional blood flow in man. Acta Physiol Scand 102: 484–491
O’Connor DT (1982) Response of the renal kallikrein-kinin system, intravascular volume, and renal hemodynamics to sodium restriction and diuretic treatment in essential hypertension. Hypertension 4 (Suppl 3): 72–78
O’Connor DT (1982) Response of the renal kallikrein-kinin system, intravascular volume, and renal hemodynamics to sodium restriction and diuretic treatment in essential hypertension. Hypertension 4 (2): 172–178
O’Connor DT, Bars AP, Amend W, Vincenti F (1982) Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function. Am J Med 73 (4): 475–481
Orstavik TB, Nustad K, Brandtzaeg P, Pierce JV (1976) Cellular origin of urinary kallikreins. J Histochem Cytochem 24: 1037–1039
Pace-Asciak CP (1976) Decreased renal prostaglandin catabolism precedes onset of hypertension in the developing spontaneously hypertensive rat. Nature 263: 510–512
Pace-Asciak CR, Carrara MC, Rangaraj G, Nicolaou KC (1978) Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive rat. Prostaglandins 15 (6): 1005–1012
Patak RB, Mookerjee C, Bentzel P, Hysert P, Babe M, Lee J (1975) Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 10: 649–659
Pierce JV, Webster ME (1961) Human plasma kallidins: Isolation and chemical studies. Biochem Biophys Res Commun 5: 363–357
Piper PJ, Vane JR (1969) Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 223: 29–35
Pipili E, Poyser NL (1982) Release of prostaglandins I2 and E2 from the perfused mesenteric arterial bed of normotensive and hypertensive rats. Effects of sympathetic nerve stimulation and norepinephrine administration. Prostaglandins 23 (4): 543–549
Pugsley DJ, Mullins R, Beilin LJ (1976) Renal prostaglandin synthesis in hypertension induced by deoxycorticosterone and sodium chloride in the rat. Clin Sci Mol Med 51 (Suppl) 3: 253s - 256s
Rathaus M, Bernheim J (1982) Effect of propranolol treatment on the urinary excretion of prostaglandins E2 and Fla in patients with essential hypertension. Isr J Med Sci 18 (2): 231–234
Rioux F, Quirion R, Regoli D (1977) The role of prostaglandins in hypertension. I. The release of prostaglandins by aorta strips of renal, DOCAsalt, and spontaneously hypertensive rats. Can J Physiol Pharmacol 55: 1330–1338
Romero JC, Strong JC (1977) The effect of indomethacin blockade of prostaglandin synthesis on blood pressure of normal rabbits and rabbits with renovascular hypertension. Circ Res 40: 35–41
Ruilope L, Garcia-Robles R, Barrientos A, Bernis C, Alcazar J, Tressuerres JA, Mancheno E, Millet VG, Sancho J, Rodicio JL (1982) The role of urinary PG E2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension. Clin Exp Hypertension 4 (6): 989–1000
Saruta T, Kondo K (1982) Endocrine factors in juvenile essential hypertension. Jpn J Med 21 (2): 152–154
Sato M, Abe K, Haruyama T, Sato K, Yasujima M, Imai Y, Hiwatari M, Kasai Y, Tajima J, Itoh S, Seino M, Chiba S, Goto T, Yoshinaga K (1982) Effect of acute water loading on urinary excretion of prostaglandin E in hypertensive patients. Prostaglandins-Leukotrienes-Med 8 (5): 517–524
Sato M, Abe K, Haruyama T, Yasujima M, Sato K, Chiba S, Imai Y, Hiwatari M, Kasai Y, Tajima J, Itoh S, Seino M, Goto T, Yoshinaga K (1982) Effect of dietary sodium intake on the metabolism of prostaglandins in the kidney in hypertensive patients. Prostaglandins-Leukotrienes-Med 8 (3): 199–209
Siren AL (1982) Differences in the central actions of arachidonic acid and prostaglandin Fla between spontaneously hypertensive and normotensive rats. Life Sci 30 (6): 503–513
Speckart P, Zia P, Zipser R, Horton R (1977) The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man. J Clin Endocrinol and Metab 44: 832–837
Spokas EG, Ferreri NR, Wong PY-K, McGiff JC (1980) Effect of 6-keto-prostaglandin E1 (6keto-PGE1) on renin release from rabbit renal cortical slices. Circulation 62: III - 287 (Abstract)
Stein JH, Congbalay RC, Karsh DL, Osgood RW, Ferris TF (1972) The effect of bradykinin on proximal tubular sodium reabsorption in the dog. Evidence for functional nephron heterogeneity. J Clin Invest 51: 1709–1721
Streeten DHP, Kerr LP, Kerr CB, Prior JC, Dalakos TG (1972) Hyperbradykininism: a new orthostatic syndrome. Lancet 2: 1048–1053
Stygles VG, Reinke DA, Rickert DE, Hook JB (1978) Increased blood pressure in the SHR is not related to a deficit in renomedullary PGE2. Experientia 15: 1025–1026
Sullivan JM, Patrick DR (1981) Release of prostaglandin I2-like activity from the rat aorta: Effect of captopril, furosemide and sodium. Prostaglandins 22: 575–585
Szczeklik A, Gryglewski RJ, Nizankowska E, Nizankowski R, Musial J (1978) Pulmonary and antiplatelet effects of intravenous and inhaled prostacyclin in man. Prostaglandins 16: 651–659
Tan SY, Sweet P, Mulrow PJ (1978) Impaired renal production of prostaglandin E2: a newly identified lesion in human essential hypertension. Prostaglandins 15 (1): 139–150
Terragno NA, Terragno DA, Pacholczyk D, McGiff JC (1974) Prostaglandins and the regulation of uterine blood flow in pregnancy. Nature 249: 57–58
Terragno DA, Crowshaw K, Terragno NA, McGiff JC (1975) Prostaglandin synthesis by bovine mesenteric arteries and veins. Circ Res (Suppl 1)36–37: I76–80
Terragno NA, Terragno DA, McGiff JC (1977) Contribution of prostaglandins to the renal circulation in conscious, anesthetized and laparotomized dogs. Circ Res 40: 590–595
Terragno NA, McGiff JC, Terragno A (1978) Synthesis of prostaglandin by vascular and non-vascular renal tissues and the presence of an endogenous prostaglandin synthesis inhibitor in the cortex. In: Vargaftig BB (ed) Advances in Pharmacology and Therapeutics, Volume 4, Prostaglandins and Immunopharmacology, Pergamon Press, Oxford, pp 39–46
Tobian L, Ganguli M, Johnson MA, Iwai J (1982) Influence of renal prostaglandins and dietary lineoleate on hypertension in Dahl S rats. Hypertension 4 (Suppl 2): II149-II 153
Vane JR (1969) The release and fate of vasoactive hormones in the circulation. Br J Pharmacol 35: 209–242
Vane JR, McGiff JC (1975) Possible contributions of endogenous prostaglandins to the control of blood pressure. Circ Res 36–37 (Suppl 1): I-68–75
Verberckmös R, van Damme B, Clement J, Amery A, Michielsen P (1976) Bartter’s syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. Kidney Int 9: 302–307
Vinci JM, Telles DA, Bowden RE, Izzo IL, Keiser HR, Radfar N, Taylor AA, Gill JR, Bartter FC (1976) The kallikrein-kinin system (KKS) in Bartter’s syndrome (BS) and its response to prostaglandin synthetase inhibition ( PGSI ). Clin Res 24: 414A
Vinci J, Zusman R, Bowden R, Horowitz D, Keiser H (1977) Relationship of urinary and plasma kinins to sodium-retaining steroids and plasma renin activity. Clin Res 25: 450A
Vinci JM, Zusman RM, Izzo IL Jr, Bowden RE, Horowitz D, Pisano JJ, Keiser HR (1979) Human urinary and plasma kinins. Relationship to sodium-retaining steroids and plasma renin activity. Circ Res 44 (2): 228–237
Ward PE, Gedney CD, Dowben RM, Erdös EG (1975) Isolation of membrane bound renal kallikrein and kininase. Biochem J 151: 755–758
Weber PC, Larsson C, Änggard E, Hamberg M, Corey EJ, Nicolaou KD, Samuelsson B (1976) Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin endoperoxides. Circ Res 39: 868–874
Weber PC, Larsson C, Scherer B (1977) Prostaglandin E2–9-ketoreductase as a mediator of salt intake-related prostaglandin-renin interaction
Weber PC, Scherer B, Larsson C (1977) Increase 280 J. M. Sullivan und J. C. McGiff of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release. Eur J Pharmacol 41: 329–332
Wennmalm Ä (1974) Hypertensive effect of the prostaglandin synthesis inhibitor indomethacin. IRCS (Research on: Endocrine System) 2: 1099
Whorton AR, Misono K, Hollifield J, Frölich JC, Inagami T, Oates JA (1977) Prostaglandins and renin release: Stimulation of renin release from rabbit renal cortical slices by PGI2. Prostaglandins 14: 1095–1104
Widimsky J, Fejfarova MD, Fejfar Z (1957) Changes of cardiac output in hypertensive disease. Cardiologia 31: 381–389
Willis LR, Ludens JH, Hook JB, Williamson HE (1969) Mechanism of natriuretic action of bradykinin. Am J Physiol 217: 1–5
Wilson TW, Loadholt CB, Privitera PJ, Halushka PV (1982) Furosemide increases urine 6-ketoprostaglandin Fla. Relation to natriuresis, vaso-dilation, and renin release. Hypertension 4: 634–641
Wong PY, Talamo RC, Williams GH, Coleman RW (1975) Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest 55: 691–698
Wong PY-K, Terragno DA, Terragno NA, McGiff JC (1977) Dual effects of bradykinin on prostaglandin metabolism: relationship to the dissimilar vascular actions of kinins. Prostaglandins 13: 1113–1125
Wong PY-K, Sun FF, McGiff JC (1978) Metabolism of prostacyclin in blood vessels. J Biol Chem 253: 5555–5557
Wong PY-K, Lee WH, Chao PH-W, Reiss RF, McGiff JC (1980) Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. J Biol Chem 255: 9021–9024
Yarger WE, Griffith LD (1974) Intrarenal hemodynamics following chronic unilateral ureteral obstruction in the dog. Am J Physiol 227: 816–826
Yuan B, Tai CL, Tai HH (1980) 9-hydroxyprostaglandin dehydrogenase from rat kidney. J Biol Chem 255: 7439–7443
Yun J, Kelly G, Bartter FC (1979) Effect of indomethacin on renal function and plasma renin activity in dogs with chronic renovascular hypertension. Nephron 24: 278–282
Zinner SH, Margolius HS, Rosner B, Keiser HR, Kass EH (1976) Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am J Epidemol 104: 124–132
Zinner SH, Margolius HS, Rosner B, Kass EH (1977) Eight year longitudinal study of blood pressure and urinary kallikrein in childhood. Clin Res 25: 266A
Zusman RM, Keiser HR (1977) Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. J Clin Invest 60: 215–223
Zusman RM, Caldwell BV, Mulrow PJ, Speroff L (1973) The role of prostaglandin A in the control of sodium homeostasis and blood pressure. Prostaglandins 3: 679–690
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sullivan, J.M., McGiff, J.C. (1984). Kallikrein-Kinin- und Prostaglandin-Systeme bei Hypertonie. In: Rosenthal, J. (eds) Arterielle Hypertonie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00760-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-00760-0_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-00761-7
Online ISBN: 978-3-662-00760-0
eBook Packages: Springer Book Archive